Status | Study |
Recruiting |
Study Name: Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Condition: Chemotherapy-induced Neutropenia Date: 2017-03-06 Interventions: Drug: Plinabulin Plinabulin (B |
Not yet recruiting |
Study Name: Improving Diagnosis in Idiopathic Cytopenia Using Gene Sequencing Condition: Cytopenia Date: 2017-01-18 Interventions: Procedure: Bone Marrow Aspirate |
Completed |
Study Name: Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia Condition: Non-Interventional Study Date: 2016-11-03 Interventions: Other: Overall satisfaction questionnaires of home use of Nivestim |
Recruiting |
Study Name: Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay Condition: Infection Neutropenia Date: 2016-09-19 |
Completed |
Study Name: Screening for Genes in Patients With Congenital Neutropenia Condition: Congenital Neutropenia Date: 2016-08-05 Interventions: Genetic: High-throughput exome sequencing |
Recruiting |
Study Name: Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients Condition: Childhood Cancer Neutropenia Date: 2016-07-27 Interventions: Other: Ciprofloxacin administration Ciprofloxacin will be administered via the PAC directly followed by |
Not yet recruiting |
Study Name: Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen® Condition: Leucocytosis Date: 2016-04-01 Interventions: Biological: Leucostim® Le |
Recruiting |
Study Name: Investigation of the Genetics of Hematologic Diseases Condition: Bone Marrow Failure Syndromes Erythrocyte Disorder Date: 2016-03-16 |
Recruiting |
Study Name: Eosinophilia Diagnosis Condition: Hypereosinophilic Syndrome Date: 2015-10-19 Interventions: Other: Scheduled exams and diagnosis Scheduled exams and diagnosis circuit as imposed by the algorithm |
Completed |
Study Name: Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion Condition: Leukocytosis Date: 2014-11-18 Interventions: Device: Spectra Optia® Apheresis System White Blood Cell Depletion |